scholarly journals Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680

Diabetes Care ◽  
2019 ◽  
Vol 42 (8) ◽  
pp. 1604.1-1604
Author(s):  
Robert Ritzel ◽  
Stewart B. Harris ◽  
Helen Baron ◽  
Hermes Florez ◽  
Ronan Roussel ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Older People ◽  
Insulin Glargine ◽  
Diabetes Care ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158

Diabetes Care ◽  
2015 ◽  
Vol 38 (3) ◽  
pp. 538-538
Author(s):  
Michael Nauck ◽  
Ruth S. Weinstock ◽  
Guillermo E. Umpierrez ◽  
Bruno Guerci ◽  
Zachary Skrivanek ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Diabetes Care ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

2020 ◽  
Vol Volume 13 ◽  
pp. 423-431 ◽  
Author(s):  
Nuntakorn Thongtang ◽  
Jirasak Piyapromdee ◽  
Natthakan Tangkittikasem ◽  
Kittichai Samaithongcharoen ◽  
Nithiwat Srikanchanawat ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Primary Prevention ◽  
High Intensity ◽  
Low Dose ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document